Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,031 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, Not Recruiting

Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

NCT04666038

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
Locations
  • Southern Cancer Center, P.C. Daphne, Alabama, United States
  • Mitchell Cancer Institute -University of South Alabama Mobile, Alabama, United States
  • Palo Verde Hematology Oncology Glendale, Arizona, United States
  • Arizona Oncology Associates, P.C. - HOPE Tucson, Arizona, United States
View all 232 locations
View Trial Details
Active, Not Recruiting

P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma

NCT04960579

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • City of Hope Goodyear, Arizona, United States
  • University of California San Diego San Diego, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Emory University Atlanta, Georgia, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy

NCT01382082

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
Locations
  • Delaware/Christiana Care NCORP Newark, Delaware, United States
  • Delaware/Christiana Care NCORP (CHRISTIANA) Newark, Delaware, United States
  • Heartland Decatur, Illinois, United States
  • Kansas City Clinical Oncology Program Prairie Village, Kansas, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

Japan Expansion Cohort: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

NCT06868667

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • GSK Investigational Site Aomori, Japan
  • GSK Investigational Site Fukuoka, Japan
  • GSK Investigational Site Himeji, Japan
  • GSK Investigational Site Kamakura, Japan
View all 16 locations
View Trial Details

Related conditions